Item Type | Name |
Concept
|
HLA Antigens
|
Concept
|
HLA-D Antigens
|
Concept
|
HLA-DP Antigens
|
Concept
|
HLA-DQ Antigens
|
Concept
|
HLA-DR Antigens
|
Concept
|
HLA-A Antigens
|
Concept
|
HLA-B Antigens
|
Concept
|
HLA-C Antigens
|
Concept
|
HLA-A2 Antigen
|
Concept
|
HLA-B7 Antigen
|
Concept
|
HLA-B8 Antigen
|
Concept
|
HLA-B35 Antigen
|
Concept
|
HLA-DRB1 Chains
|
Concept
|
HLA-DQ beta-Chains
|
Concept
|
HLA-A24 Antigen
|
Concept
|
HLA-B13 Antigen
|
Concept
|
HLA-B15 Antigen
|
Concept
|
HLA-B18 Antigen
|
Concept
|
HLA-G Antigens
|
Academic Article
|
HLA class I molecules consistently present internal influenza epitopes.
|
Academic Article
|
HLA-B15 peptide ligands are preferentially anchored at their C termini.
|
Academic Article
|
Precision genotyping of human leukocyte antigen-A, -B and -C loci via direct DNA sequencing.
|
Academic Article
|
C-terminal epitope tagging facilitates comparative ligand mapping from MHC class I positive cells.
|
Academic Article
|
Non-conservative substitutions distinguish previously uncharacterized HLA-A molecules.
|
Academic Article
|
Disparate binding of chaperone proteins by HLA-A subtypes.
|
Academic Article
|
Identification of an HLA A*0201-restricted CD8(+) T-cell epitope for the glycoprotein B homolog of human herpesvirus 8.
|
Academic Article
|
Population of the HLA ligand database.
|
Academic Article
|
A charged amino acid residue in the transmembrane/cytoplasmic region of tapasin influences MHC class I assembly and maturation.
|
Academic Article
|
Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing.
|
Academic Article
|
Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes.
|
Academic Article
|
An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer.
|
Academic Article
|
A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais.
|
Academic Article
|
HLA-B*35-PX and HLA-B*35-PY subtype differentiation does not predict observed differences in level of HIV control in a Peruvian MSM cohort.
|
Academic Article
|
The HLA-C*04: 01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression.
|
Academic Article
|
Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.
|
Academic Article
|
The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference.
|
Academic Article
|
Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.
|
Academic Article
|
The Intergenic Recombinant HLA-B*46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands.
|
Academic Article
|
Characterization of baboon class I major histocompatibility molecules. Implications for baboon-to-human xenotransplantation.
|
Academic Article
|
Polymorphism at codons 114, 116, 145, and 163 muddle the typing of HLA-B*1304.
|
Academic Article
|
Alpha-2 domain polymorphism and HLA class I peptide loading.
|
Academic Article
|
Sequence-based typing of HLA class I alleles in Alaskan Yupik Eskimo.
|
Academic Article
|
HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction.
|
Academic Article
|
HLA antigens, alleles and haplotypes among the Yup'ik Alaska natives: report of the ASHI Minority Workshops, Part II.
|
Academic Article
|
Heterozygosity or homozygosity for 2 HLA class II haplotypes predict favorable outcomes for renal cell carcinoma treated with cytokine therapy.
|
Academic Article
|
Cutting edge: class I presentation of host peptides following HIV infection.
|
Academic Article
|
HLA alleles and haplotypes among the Lakota Sioux: report of the ASHI minority workshops, part III.
|
Academic Article
|
Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons.
|
Academic Article
|
Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201--a new tool for epitope discovery.
|
Academic Article
|
T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease.
|
Academic Article
|
Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes.
|
Academic Article
|
Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells.
|
Academic Article
|
A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs.
|
Academic Article
|
Identification of breast cancer peptide epitopes presented by HLA-A*0201.
|
Academic Article
|
Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity.
|
Academic Article
|
T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope.
|
Academic Article
|
Surface phenotype and functionality of WNV specific T cells differ with age and disease severity.
|
Academic Article
|
Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires.
|
Academic Article
|
Identification of class I HLA T cell control epitopes for West Nile virus.
|
Academic Article
|
Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove.
|
Academic Article
|
T cells from patients with Parkinson's disease recognize a-synuclein peptides.
|
Academic Article
|
Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.
|
Academic Article
|
Description of a modified sequencing strategy and the molecular characterization of HLA-B*8201.
|
Academic Article
|
Nucleotide sequence analysis of HLA-B*1523 and B*8101. Dominant alpha-helical motifs produce complex serologic recognition patterns for the HLA-B"DT" and HLA-B"NM5" antigens.
|
Academic Article
|
Molecular characterization of HLA-A*6803.
|
Academic Article
|
Novel alleles HLA-B*7802 and B*51022: evidence for convergency in the HLA-B5 family.
|
Academic Article
|
Complexity among constituents of the HLA-B*1501 peptide motif.
|
Academic Article
|
Characterization of an HLA-A26 serologic variant.
|
Academic Article
|
Sequence-based typing provides a new look at HLA-C diversity.
|
Academic Article
|
Toward a definition of self: proteomic evaluation of the class I peptide repertoire.
|
Academic Article
|
Critical factors in the development of fluorescence polarization-based peptide binding assays: an equilibrium study monitoring specific peptide binding to soluble HLA-A*0201.
|
Academic Article
|
Amyloid precursor-like protein 2 association with HLA class I molecules.
|
Academic Article
|
Profiling antibodies to class II HLA in transplant patient sera.
|
Academic Article
|
Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells.
|
Academic Article
|
T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells.
|
Academic Article
|
Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501.
|
Academic Article
|
Peptide motif of the class I molecule HLA-B*1503.
|
Academic Article
|
Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization.
|
Academic Article
|
Rhesus macaque MHC class I molecules present HLA-B-like peptides.
|
Academic Article
|
HLA class I molecules reflect an altered host proteome after influenza virus infection.
|
Academic Article
|
Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection.
|
Academic Article
|
Proteome sampling by the HLA class I antigen processing pathway.
|
Academic Article
|
Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity.
|
Academic Article
|
Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.
|
Academic Article
|
Complementary IMAC enrichment methods for HLA-associated phosphopeptide identification by mass spectrometry.
|
Academic Article
|
Determinants governing T cell receptor a/ß-chain pairing in repertoire formation of identical twins.
|
Grant
|
FUNCTIONAL SIGNIFICANCE OF HLA CLASS I POLYMORPHISM
|
Grant
|
BAA-APPLICATION OF HLA DATA TO DEVELOP &IMPROVE VACCINE
|
Grant
|
Discovery and Targeting of West Nile Virus Epitopes
|
Grant
|
Human natural killer cell recognition of cytomegalovirus
|
Grant
|
Discovery and Targeting of HIV-1 Associated Antigens
|
Grant
|
Direct Discovery of HLA-associated Influenza Epitopes
|
Academic Article
|
Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides.
|
Academic Article
|
Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome.
|
Academic Article
|
Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning.
|
Academic Article
|
Molecular characterization of the archaic HLA-B*73:01 allele reveals presentation of a unique peptidome and skewed engagement by KIR2DL2.
|